ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Clinical trials for ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common immune treatment save lives during sudden lung scarring attacks?
Disease control Recruiting nowThis study tests whether adding intravenous immunoglobulin (IVIG) to standard care helps people hospitalized with a sudden, severe worsening of idiopathic pulmonary fibrosis (IPF). About 196 adults with IPF who are having an acute exacerbation will receive either usual treatment …
Matched conditions: ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Argyrios Tzouvelekis • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can steroids save lives during IPF Flare-Ups? new trial aims to find out
Disease control Recruiting nowThis Phase 3 trial tests whether high-dose steroids (methylprednisolone and prednisone) can reduce deaths within 30 days for people hospitalized with a sudden worsening of idiopathic pulmonary fibrosis (IPF). About 110 adults with IPF and an acute exacerbation will receive either…
Matched conditions: ACUTE EXACERBATION OF IDIOPATHIC PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC